Treatments for heart valve disease
Slightly diseased heart valves are usually just monitored. If symptoms arise or a check-up reveals that the problem has become worse, various treatment options can be considered. The heart valve is often replaced with an artificial one, but other approaches are sometimes possible too.
The procedure – which is either done using a catheter or open heart surgery – is quite complex to plan and carry out. Because of this, people who have heart valve disease are cared for by a multidisciplinary team of doctors who often work together with special hospitals (heart centers).
The treatment decision will depend on many individual factors, including your age, whether you have other medical conditions too, the cause and severity of the heart valve disease, as well as which heart valve is affected, and how badly.
Treating narrowed aortic valves (aortic valve stenosis)
Aortic valve stenosis is the most common type of heart valve disease in Germany and similar countries. It occurs when the valve between the lower left heart chamber (left ventricle) and the aorta (main artery) becomes too narrow. As a result, the heart has to work harder to pump enough blood around your body. If that causes problems or if there is a risk of complications, the narrowed valve is usually replaced with an artificial (prosthetic) heart valve. This may have to be done through open heart surgery, but artificial heart valves can often be implanted using a catheter instead. There are two types of artificial heart valves:
- Mechanical prosthetic valves: Various types of prosthetic valves can take on the function of the natural heart valve. These artificial valves are made out of metal or a synthetic material. If they close properly, you can hear a quiet clicking sound every time the heart beats. The advantage of mechanical valves is that they last a long time. For this reason, they are mainly used in younger people – but they generally aren’t used much nowadays. The disadvantage of mechanical valves is that blood clots may form on them and block the whole valve (prosthetic valve thrombosis). Blood clots might also break free and travel around the body in the bloodstream, where they may block a blood vessel (embolism). If that happens in the brain, it leads to a stroke. In order to prevent these kinds of complications, people who have a mechanical prosthetic heart valve take blood-thinning (anticoagulant) medication for the rest of their life. This medication can lead to side effects such as bruising. Severe bleeding in the gastrointestinal (digestive) tract or brain are rare but potentially life-threatening side effects.
- Bioprosthetic (tissue) valves: This kind of replacement valve is made out of biological tissue such as the heart tissue of cows or pigs. Sometimes, but only very rarely, the donated heart valves of people who have passed away are used. People who have a bioprosthetic valve don’t necessarily have to take anticoagulants to reduce blood clotting. But these valves don’t last as long as mechanical valves do: For instance, there is an increased risk of bioprosthetic aortic valves becoming stiff and thicker after 10 to 15 years, and further surgery may then be needed. Bioprosthetic heart valves are generally used in people over the age of 60 or in younger people who can’t take blood-thinning medication over the long term.
In some young people the aortic valve can be replaced with a different heart valve of theirs. The heart valve between their right ventricle and their pulmonary artery (the pulmonary valve) is removed and used to replace the diseased aortic valve. The removed pulmonary valve is replaced with a bioprosthetic valve. Prosthetic heart valves last longer in that position because there is less strain on them there.
Treating mitral valves that don’t close properly (regurgitation)
The second most common type of heart valve disease is known as mitral regurgitation or mitral insufficiency. It occurs when the valve between the left atrium (upper heart chamber) and the left ventricle (lower heart chamber) doesn’t close tightly. This means that when the left ventricle contracts (squeezes), some of the blood flows back into the left ventricle rather than into the body.
Like aortic valve stenosis, mitral valve regurgitation can be treated with a prosthetic heart valve. But faulty mitral valves are usually repaired rather than replaced. This is done using a catheter procedure or through open heart surgery.
Doctors call this type of treatment “heart valve repair.” Depending on the problem, the heart valve can be repaired in different ways. For instance, it can be strengthened a little using tissue taken from the sac surrounding the heart (the pericardium). If the mitral valve is leaky because it is no longer properly attached to the heart muscle, it can be reconnected using a strong thread made from synthetic material. If the valve is too wide, it can be tightened by implanting an artificial ring, allowing the valve to close better again.
In a different procedure, a small metal clip is used to clip the flaps of the leaky valve together, helping the valve to shut properly again.
Treating other types of heart valve disease
The above-mentioned treatment approaches can also be used to treat less common types of heart valve disease. If the aortic valve is leaky (aortic regurgitation), heart valve repair can help. But it usually makes more sense to replace the valve.
What happens during catheter treatment and open heart surgery?
In catheter treatment, a thin tube (catheter) is inserted into a blood vessel through a small cut – usually in the groin. The catheter is pushed through the blood vessel into the heart. Devices and instruments such as a prosthetic aortic valve or a mitral valve clip can be guided into the heart through the catheter. Catheter procedures are less likely to result in complications like wound healing problems or infections. Instead, they tend to lead to side effects such as an irregular heartbeat (arrhythmia) or damage caused by the catheter. But people usually recover faster from catheter procedures than they do from open heart therapy. Research hasn't yet shown whether catheter treatment also has more advantages in the long term, though.
In open heart surgery, the rib cage is opened under general anesthesia. The heartbeat is stopped. During the operation, a heart-lung machine (cardiopulmonary bypass machine) pumps the blood around the body instead. This kind of operation puts a strain on your body and it takes some time for the wound to heal. The possible complications include bleeding and infections. Complications are more likely to occur in people who are old, frail or already weakened by a different health problem.
It is sometimes possible to do the surgery through a smaller incision (cut) instead, though. This is known as keyhole surgery or minimally invasive surgery. Keyhole surgery is generally only done if catheter treatment or open heart surgery aren't possible.
Can medication help too?
Although medication can’t fix heart valve problems, it is sometimes part of the treatment – for instance, the blood-thinning (anticoagulant) medication that is used after receiving a prosthetic heart valve. But medication can also help if heart valve disease has led to other health problems, such as heart failure. Blood-pressure-lowering medication or diuretics (“water pills”) can then be used.
Is treatment always necessary?
If someone only has slightly diseased heart valves without any symptoms, they often don't need treatment. Instead, they usually have regular check-ups to see whether the function of the valve is getting worse or whether they have started noticing any symptoms. But very frail people who have severe heart valve disease may also decide not to have treatment if it wouldn’t help them live longer or improve their quality of life.
Ak A, Porokhovnikov I, Kuethe F, Schulze PC, Noutsias M, Schlattmann P. Transcatheter vs. surgical aortic valve replacement and medical treatment: Systematic review and meta-analysis of randomized and non-randomized trials. Herz 2018; 43(4): 325-337.
Ansari MT, Ahmadzai N, Coyle K, Coyle D, Moher D. Mitral Valve Clip for Treatment of Mitral Regurgitation: An Evidence-Based Analysis. Ont Health Technol Assess Ser 2015; 15(12): 1-104.
Baumgartner H, Cremer J, Eggebrecht H, Diegeler A, Hamm C, Welz A et al. Kommentar zu den Leitlinien (2017) der ESC/EACTS zum Management von Herzklappenerkrankungen. Kardiologe 2018; 12: 184-193.
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38(36): 2739-2791.
Burrage M, Moore P, Cole C, Cox S, Lo WC, Rafter A et al. Transcatheter Aortic Valve Replacement is Associated with Comparable Clinical Outcomes to Open Aortic Valve Surgery but with a Reduced Length of In-Patient Hospital Stay: A Systematic Review and Meta-Analysis of Randomised Trials. Heart Lung Circ 2017; 26(3): 285-295.
Elmaraezy A, Ismail A, Abushouk AI, Eltoomy M, Saad S, Negida A et al. Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis. BMC Cardiovasc Disord 2017; 17(1): 234.
Foroutan F, Guyatt GH, O'Brien K, Bain E, Stein M, Bhagra S et al. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ 2016; 354: i5065.
Gargiulo G, Sannino A, Capodanno D, Barbanti M, Buccheri S, Perrino C et al. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-analysis. Ann Intern Med 2016; 165(5): 334-344.
Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. New York: McGraw-Hill; 2015.
Ludwig Boltzmann Institut (LBI). Perkutane Mitralklappenreparatur bei chronischer Mitralklappeninsuffizienz (Mitraclip®, Carillon®, NeoChord DS1000). Deutsche Kurzfassung zum gleichnamigen EUnetHTA Bericht. LBI Health Technology Assessment. Decision Support Document Nr.: 93. 2015.
Moscarelli M, Fattouch K, Casula R, Speziale G, Lancellotti P, Athanasiou T. What Is the Role of Minimally Invasive Mitral Valve Surgery in High-Risk Patients? A Meta-Analysis of Observational Studies. Ann Thorac Surg 2016; 101(3): 981-989.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al. 2014 AHA / ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63(22): e57-185.
Tam DY, Vo TX, Wijeysundera HC, Ko DT, Rocha RV, Friedrich J et al. Transcatheter vs Surgical Aortic Valve Replacement for Aortic Stenosis in Low-Intermediate Risk Patients: A Meta-analysis. Can J Cardiol 2017; 33(9): 1171-1179.
Zhao DF, Seco M, Wu JJ, Edelman JB, Wilson MK, Vallely MP et al. Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis. Ann Thorac Surg 2016; 102(1): 315-327.
IQWiG health information is written with the aim of helping
people understand the advantages and disadvantages of the main treatment options and health
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.